EichorEICHOR
Location: Yamanashi Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Yamanashi

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Pfizer · NCT05895786EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Eli Lilly and Company · NCT06338995Software as a Medical Device for the Treatment of Patients With PTSD
Phase 2/Phase 3 · Yamanashi Prefectural Kita Hospital · Otsuka Medical Devices Co., Ltd. Japan · NCT06589505A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Takeda · NCT06963827ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase 3 · University of Yamanashi Hospital · Ono Pharmaceutical Co., Ltd. · NCT06579573A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Pfizer · NCT07629440Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Eli Lilly and Company · NCT07223593Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Phase N/A · Research Site · AstraZeneca · NCT05454787A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Janssen Research & Development, LLC · NCT07258511Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Phase 1 · Novartis Pharmaceuticals · NCT07340138A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymph
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT06090539A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Yamanashi Prefectural Central Hospital · Janssen Research & Development, LLC · NCT05552222Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
Phase 4 · Nippon Medical School · NCT07111559A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · Yamanashi Prefectural Central Hospital · Janssen Research & Development, LLC · NCT07577856BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 3 · Pfizer · NCT07160244MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Pfizer · NCT06152575Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · Amgen · NCT07293260Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Phase 3 · PharmaEssentia Japan K.K. · NCT04655092A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Phase 3 · Eli Lilly and Company · NCT07222137Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
Phase N/A · City of Hope Medical Center · NCT06490003A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · AbbVie · NCT06389136A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Pr
Phase 3 · Merck Sharp & Dohme LLC · NCT06717347Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
Phase N/A · City of Hope Medical Center · NCT06476067A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Phase 3 · Incyte Corporation · NCT07623200A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone
Phase 3 · Regeneron Pharmaceuticals · NCT05730036A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Phase 2 · Yamanashi Prefectural Central Hospital · Takeda · NCT07319845A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07227311Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Particip
Phase 3 · AbbVie · NCT06158841
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.